How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

The Ban Artificial Superintelligence Act identifies real failures in AI governance. But its publicly released definition ...

AI Coding Tip 030 - Turn Repeatable Skill Steps Into Tested Scripts Instead of Prompts 20 August —OpenCode announces the ...

OpenAI opened an incident on its official status page on September 3, 2026, after detecting elevated errors across ChatGPT ...

If you encounter the error message, Something went wrong, Error 1200 while trying to sign in to OneDrive, Outlook, Teams, or any other Microsoft Service using your ...

Microsoft Store is an app store on Windows PC. We can download software programs without any fear of malware as they are monitored before installation. Apps we ...

A previous online version of this story incorrectly stated that the average American home uses slightly less than one kilowatt of electricity per month, in fact, it is slightly less than one ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...